Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Anders Hartmann"'
Autor:
Trond Jenssen, My Svensson, Jens Bollerslev, Kristin Godang, Erik Berg Schmidt, Hanne Skou Jørgensen, Anders Hartmann, Ivar Eide, Anders Åsberg
Publikováno v:
Nutrients
Jørgensen, H S, Eide, I A, Jenssen, T, Åsberg, A, Bollerslev, J, Godang, K, Hartmann, A, Schmidt, E B & Svensson, M 2021, ' Marine n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Kidney Transplant Recipients : A Randomized, Placebo-Controlled Trial ', Nutrients, vol. 13, no. 7, 2361 . https://doi.org/10.3390/nu13072361
Nutrients, Vol 13, Iss 2361, p 2361 (2021)
Jørgensen, H S, Eide, I A, Jenssen, T, Åsberg, A, Bollerslev, J, Godang, K, Hartmann, A, Schmidt, E B & Svensson, M 2021, ' Marine n-3 polyunsaturated fatty acids and bone mineral density in kidney transplant recipients : A randomized, placebo-controlled trial ', Nutrients, vol. 13, no. 7, 2361 . https://doi.org/10.3390/nu13072361
Volume 13
Issue 7
Jørgensen, H S, Eide, I A, Jenssen, T, Åsberg, A, Bollerslev, J, Godang, K, Hartmann, A, Schmidt, E B & Svensson, M 2021, ' Marine n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Kidney Transplant Recipients : A Randomized, Placebo-Controlled Trial ', Nutrients, vol. 13, no. 7, 2361 . https://doi.org/10.3390/nu13072361
Nutrients, Vol 13, Iss 2361, p 2361 (2021)
Jørgensen, H S, Eide, I A, Jenssen, T, Åsberg, A, Bollerslev, J, Godang, K, Hartmann, A, Schmidt, E B & Svensson, M 2021, ' Marine n-3 polyunsaturated fatty acids and bone mineral density in kidney transplant recipients : A randomized, placebo-controlled trial ', Nutrients, vol. 13, no. 7, 2361 . https://doi.org/10.3390/nu13072361
Volume 13
Issue 7
Kidney transplant recipients are at high risk of progressive bone loss and low-energy fractures in the years following transplantation. Marine n-3 polyunsaturated fatty acids (n-3 PUFA) supplementation may have beneficial effects on bone strength. Th
Autor:
Tomm Bernklev, Cathrine Brunborg, Kristian Heldal, Marit Helen Andersen, Nanna von der Lippe, Anders Hartmann, Karsten Midtvedt, Anna Varberg Reisæter, Kjersti Lønning, Pål-Dag Line
Publikováno v:
Nephrology. 23:948-956
Aim There is limited available knowledge regarding health-related quality of life (HRQoL) in older patients with chronic kidney disease. We aimed to describe HRQoL in renal transplant candidates 65 years or older at transplant acceptance, and during
Autor:
Bartlomiej J. Witczak, Søren E. Pischke, Anna V. Reisæter, Karsten Midtvedt, Judith K. Ludviksen, Kristian Heldal, Trond Jenssen, Anders Hartmann, Anders Åsberg, Tom E. Mollnes
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
BackgroundThe major reason for graft loss is chronic tissue damage, as interstitial fibrosis and tubular atrophy (IF/TA), where complement activation may serve as a mediator. The association of complement activation in a stable phase early after kidn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63d31ac35833d2d06e16339496322ecc
https://hdl.handle.net/11250/2978646
https://hdl.handle.net/11250/2978646
Autor:
Karsten Midtvedt, Geir Mjøen, Anna V. Reisæter, Anders Hartmann, Hallvard Holdaas, Dag Olav Dahle, Hege Pihlstrøm, Tom Grotmol, Hege Næss, Torbjørn Leivestad
Publikováno v:
Transplantation. 101:2599-2605
Kidney transplantation in recipients with a previous malignancy is often deferred 2 to 5 years after cancer treatment due to fear of cancer recurrence. In Norway, the required waiting period has been 1 year.We compared patient and graft survival of r
Autor:
Thea Anine Strøm Halden, Trond Jenssen, Anders Åsberg, Dag Olav Dahle, Ivar Eide, Anders Hartmann
Publikováno v:
Transplantation. 101:1282-1289
Previous reports indicate that posttransplantation diabetes mellitus (PTDM) is associated with overall renal graft loss, but not death-censored graft loss.In this single-center retrospective cohort study of 2749 adult Norwegian renal transplant recip
Autor:
Ole Øyen, Anne Günther, Svend Aakhus, Jørn Petter Lindahl, Hallvard Holdaas, Torbjørn Leivestad, Richard Massey, Knut Endresen, Trond Jenssen, Anders Hartmann, Rune Horneland, Karsten Midtvedt
Publikováno v:
Transplantation. 101:1261-1267
In recipients with type 1 diabetes, we aimed to determine whether long-term normoglycemia achieved by successful simultaneous pancreas and kidney (SPK) transplantation could beneficially affect progression of coronary artery disease (CAD) when compar
Autor:
Anders Hartmann, Kjersti Lønning, Torbjørn Leivestad, Pål-Dag Line, Karsten Midtvedt, Kristian Heldal, Anna Varberg Reisæter
Publikováno v:
Transplantation. 100:2705-2709
Elderly patients are the fastest-growing group in need of renal transplantation. This study puts focus on renal transplant recipients in their 80th year or longer at time of engraftment. Is there evidence to support an absolute upper age limit for re
Autor:
Helge Scott, Dag Olav Dahle, Karsten Midtvedt, Trond Jenssen, Trygve Syversveen, Anders Hartmann, Hallvard Holdaas, Finn P. Reinholt, Linda Flaa-Johnsen, Anna Varberg Reisæter, Geir Mjøen, Christina Dörje
Publikováno v:
Clinical Transplantation. 30:802-809
Introduction There is an uncertainty whether total inflammation in early protocol kidney graft biopsies is associated with fibrosis progression. We investigated whether total inflammation, both in fibrotic and non-fibrotic areas, at week 6 would pred
Autor:
Dag Olav Dahle, Anders Åsberg, Anna Varberg Reisæter, Thea Anine Strøm Halden, Anders Hartmann, Ivar Eide, Trond Jenssen
Publikováno v:
Transplant International. 29:568-578
Current diagnostic criteria for post-transplantation diabetes mellitus (PTDM) are either fasting plasma glucose ≥7.0 mmol/l (≥126 mg/dl) or postchallenge plasma glucose ≥11.1 mmol/l (≥200 mg/dl) 2 h after glucose administration [oral glucose
Autor:
Geir Mjøen, Anders Åsberg, Anders Hartmann, Hege Pihlstrøm, Trond Jenssen, Torbjørn Leivestad, Ivar Eide, Hallvard Holdaas, Morten W. Fagerland, Dag Olav Dahle
Publikováno v:
Transplantation. 99:1730-1737
Background The association between aortic stiffness and all-cause mortality in kidney transplant recipients (KTRs) is uncertain, and aortic stiffness has not yet been incorporated into risk prediction tools. Methods During 2007 to 2012, we measured c